Japan BCG Laboratory specializes in the development and production of BCG (Bacillus Calmette-Guérin) vaccines and related products aimed at combating tuberculosis. Their offerings include a freeze-dried BCG vaccine for intradermal use, which is indicated for active immunization against tuberculosis in infants and older children. This product is packaged in ampoules containing specific dosages of BCG and a diluent, with strict storage requirements to maintain efficacy. Additionally, they provide a freeze-dried BCG vaccine for percutaneous use, which is administered using a multi-puncture device, highlighting their commitment to innovative delivery methods for vaccination.

In addition to vaccines, Japan BCG Laboratory produces a purified protein derivative (PPD) for the intradermal Mantoux test, which is essential for diagnosing tuberculosis infection. This product is designed for accurate skin testing and requires careful storage and handling to ensure stability. Furthermore, they offer the Immunobladder® intravesical product, which is used in the treatment of specific urinary bladder conditions, demonstrating the laboratory's diverse applications of BCG technology beyond vaccination. Overall, Japan BCG Laboratory emphasizes reliable and effective solutions for tuberculosis prevention and treatment, catering to both domestic and international markets.

Japan

Japan BCG Laboratory was established in 1952 and has produced high-quality BCG (Bacillus Calmette Guérin) vaccine ever since. Japan BCG Laboratory is the sole supplier of this vaccine in Japan.
Working with UNICEF, WHO and the Pan American Health Organization (PAHO), Japan BCG Laboratory has distributed its BCG vaccine in more than 50 countries worldwide and has become a respected and longstanding supplier of high-quality products.
Japan BCG Laboratory has supplied more than 2.25 billion doses of BCG vaccine for more than 50 years.

Japan BCG Laboratory

Company Details